Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.
Clin Pharmacol Ther
; 100(6): 730-742, 2016 12.
Article
em En
| MEDLINE
| ID: mdl-27626221
ABSTRACT
Earlier patient access to beneficial therapeutics that addresses unmet need is one of the main requirements of innovation in global healthcare systems already burdened by unsustainable budgets. "Adaptive pathways" encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Mecanismo de Reembolso
/
Atenção à Saúde
/
Acessibilidade aos Serviços de Saúde
/
Necessidades e Demandas de Serviços de Saúde
Tipo de estudo:
Health_economic_evaluation
/
Sysrev_observational_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Clin Pharmacol Ther
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Reino Unido